Publication Information

{'id': 'https://openalex.org/W2620774379', 'doi': 'https://doi.org/10.1080/17425255.2017.1337746', 'title': 'Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab', 'display_name': 'Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab', 'publication_year': 2017, 'publication_date': '2017-06-02', 'ids': {'openalex': 'https://openalex.org/W2620774379', 'doi': 'https://doi.org/10.1080/17425255.2017.1337746', 'mag': '2620774379', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/28571477'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/17425255.2017.1337746', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S102336391', 'display_name': 'Expert Opinion on Drug Metabolism & Toxicology', 'issn_l': '1742-5255', 'issn': ['1742-5255', '1744-7607'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5062949690', 'display_name': 'Milos Dokmanovic', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}, {'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Milos Dokmanovic', 'raw_affiliation_strings': ['Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA'], 'affiliations': [{'raw_affiliation_string': 'Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA', 'institution_ids': ['https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044964773', 'display_name': 'Kathryn E. King', 'orcid': 'https://orcid.org/0000-0001-6357-0930'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kathryn E. King', 'raw_affiliation_strings': ['Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA'], 'affiliations': [{'raw_affiliation_string': 'Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110491899', 'display_name': 'Nishant Mohan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nishant Mohan', 'raw_affiliation_strings': ['Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA'], 'affiliations': [{'raw_affiliation_string': 'Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101545522', 'display_name': 'Yukinori Endo', 'orcid': 'https://orcid.org/0000-0002-6484-5358'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yukinori Endo', 'raw_affiliation_strings': ['Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA'], 'affiliations': [{'raw_affiliation_string': 'Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5091748729', 'display_name': 'Wen Jin Wu', 'orcid': 'https://orcid.org/0000-0001-5063-0957'}, 'institutions': [{'id': 'https://openalex.org/I1333606569', 'display_name': 'Center for Drug Evaluation and Research', 'ror': 'https://ror.org/00yf3tm42', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070', 'https://openalex.org/I1333606569']}, {'id': 'https://openalex.org/I1320320070', 'display_name': 'United States Food and Drug Administration', 'ror': 'https://ror.org/034xvzb47', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1320320070']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Wen Jin Wu', 'raw_affiliation_strings': ['Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA'], 'affiliations': [{'raw_affiliation_string': 'Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA', 'institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5091748729'], 'corresponding_institution_ids': ['https://openalex.org/I1333606569', 'https://openalex.org/I1320320070'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.39, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 23, 'citation_normalized_percentile': {'value': 0.570727, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 91, 'max': 92}, 'biblio': {'volume': '13', 'issue': '7', 'first_page': '755', 'last_page': '766'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12505', 'display_name': 'Peptidase Inhibition and Analysis', 'score': 0.996, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9837, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/cardiotoxicity', 'display_name': 'Cardiotoxicity', 'score': 0.9704499}, {'id': 'https://openalex.org/keywords/drug-development', 'display_name': 'Drug Development', 'score': 0.41344202}, {'id': 'https://openalex.org/keywords/cardiac-dysfunction', 'display_name': 'Cardiac Dysfunction', 'score': 0.41158634}], 'concepts': [{'id': 'https://openalex.org/C2779786085', 'wikidata': 'https://www.wikidata.org/wiki/Q412616', 'display_name': 'Trastuzumab', 'level': 4, 'score': 0.97050464}, {'id': 'https://openalex.org/C2778233292', 'wikidata': 'https://www.wikidata.org/wiki/Q2118956', 'display_name': 'Cardiotoxicity', 'level': 3, 'score': 0.9704499}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.85927767}, {'id': 'https://openalex.org/C2778198053', 'wikidata': 'https://www.wikidata.org/wiki/Q181754', 'display_name': 'Heart failure', 'level': 2, 'score': 0.5268446}, {'id': 'https://openalex.org/C177713679', 'wikidata': 'https://www.wikidata.org/wiki/Q679690', 'display_name': 'Intensive care medicine', 'level': 1, 'score': 0.45831794}, {'id': 'https://openalex.org/C64903051', 'wikidata': 'https://www.wikidata.org/wiki/Q2198549', 'display_name': 'Drug development', 'level': 3, 'score': 0.41344202}, {'id': 'https://openalex.org/C2993469949', 'wikidata': 'https://www.wikidata.org/wiki/Q181754', 'display_name': 'Cardiac dysfunction', 'level': 3, 'score': 0.41158634}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.39910427}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.35176587}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.3371752}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.31156844}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.30880666}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.29087186}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.17509148}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D066126', 'descriptor_name': 'Cardiotoxicity', 'qualifier_ui': 'Q000209', 'qualifier_name': 'etiology', 'is_major_topic': True}, {'descriptor_ui': 'D000068878', 'descriptor_name': 'Trastuzumab', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D066126', 'descriptor_name': 'Cardiotoxicity', 'qualifier_ui': 'Q000503', 'qualifier_name': 'physiopathology', 'is_major_topic': False}, {'descriptor_ui': 'D066126', 'descriptor_name': 'Cardiotoxicity', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015195', 'descriptor_name': 'Drug Design', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004353', 'descriptor_name': 'Drug Evaluation, Preclinical', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': False}, {'descriptor_ui': 'D004353', 'descriptor_name': 'Drug Evaluation, Preclinical', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058990', 'descriptor_name': 'Molecular Targeted Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018719', 'descriptor_name': 'Receptor, ErbB-2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018719', 'descriptor_name': 'Receptor, ErbB-2', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D013274', 'descriptor_name': 'Stomach Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013274', 'descriptor_name': 'Stomach Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D013274', 'descriptor_name': 'Stomach Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D000068878', 'descriptor_name': 'Trastuzumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068878', 'descriptor_name': 'Trastuzumab', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D000068878', 'descriptor_name': 'Trastuzumab', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1080/17425255.2017.1337746', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S102336391', 'display_name': 'Expert Opinion on Drug Metabolism & Toxicology', 'issn_l': '1742-5255', 'issn': ['1742-5255', '1744-7607'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/28571477', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.59, 'display_name': 'Good health and well-being'}], 'grants': [{'funder': 'https://openalex.org/F4320332163', 'funder_display_name': 'U.S. Food and Drug Administration', 'award_id': 'Project ID: 750912CDR'}], 'datasets': [], 'versions': [], 'referenced_works_count': 132, 'referenced_works': ['https://openalex.org/W1547968596', 'https://openalex.org/W1577063771', 'https://openalex.org/W1598574283', 'https://openalex.org/W1665419471', 'https://openalex.org/W1684135213', 'https://openalex.org/W1941265576', 'https://openalex.org/W1943807104', 'https://openalex.org/W1963690717', 'https://openalex.org/W1964808503', 'https://openalex.org/W1964978949', 'https://openalex.org/W1968206186', 'https://openalex.org/W1970029906', 'https://openalex.org/W1970893866', 'https://openalex.org/W1972512493', 'https://openalex.org/W1972647835', 'https://openalex.org/W1974223809', 'https://openalex.org/W1978634105', 'https://openalex.org/W1978752343', 'https://openalex.org/W1982210988', 'https://openalex.org/W1983159086', 'https://openalex.org/W1983530651', 'https://openalex.org/W1985937921', 'https://openalex.org/W1987196222', 'https://openalex.org/W1987609917', 'https://openalex.org/W1990864926', 'https://openalex.org/W1992656581', 'https://openalex.org/W1993804787', 'https://openalex.org/W1997218466', 'https://openalex.org/W2002273560', 'https://openalex.org/W2003867647', 'https://openalex.org/W2007283339', 'https://openalex.org/W2011952494', 'https://openalex.org/W2013429820', 'https://openalex.org/W2014053430', 'https://openalex.org/W2016010426', 'https://openalex.org/W2017624575', 'https://openalex.org/W2022669480', 'https://openalex.org/W2022857169', 'https://openalex.org/W2029542561', 'https://openalex.org/W2031944234', 'https://openalex.org/W2032703273', 'https://openalex.org/W2035123975', 'https://openalex.org/W2035642783', 'https://openalex.org/W2037690883', 'https://openalex.org/W2040512733', 'https://openalex.org/W2043704268', 'https://openalex.org/W2044355123', 'https://openalex.org/W2045161311', 'https://openalex.org/W2045324973', 'https://openalex.org/W2050036109', 'https://openalex.org/W2050674912', 'https://openalex.org/W2051357882', 'https://openalex.org/W2052397596', 'https://openalex.org/W2054012275', 'https://openalex.org/W2056220279', 'https://openalex.org/W2057044649', 'https://openalex.org/W2059137112', 'https://openalex.org/W2066048575', 'https://openalex.org/W2067864677', 'https://openalex.org/W2069213920', 'https://openalex.org/W2070251374', 'https://openalex.org/W2070515279', 'https://openalex.org/W2073072152', 'https://openalex.org/W2074527519', 'https://openalex.org/W2075966869', 'https://openalex.org/W2077534178', 'https://openalex.org/W2083486298', 'https://openalex.org/W2087236585', 'https://openalex.org/W2088777383', 'https://openalex.org/W2090149045', 'https://openalex.org/W2090589796', 'https://openalex.org/W2093049418', 'https://openalex.org/W2093743265', 'https://openalex.org/W2094506831', 'https://openalex.org/W2095059099', 'https://openalex.org/W2096869304', 'https://openalex.org/W2099180737', 'https://openalex.org/W2101253730', 'https://openalex.org/W2102653247', 'https://openalex.org/W2105384253', 'https://openalex.org/W2105436256', 'https://openalex.org/W2107427447', 'https://openalex.org/W2107672065', 'https://openalex.org/W2109817042', 'https://openalex.org/W2116753215', 'https://openalex.org/W2118371851', 'https://openalex.org/W2118447251', 'https://openalex.org/W2120171585', 'https://openalex.org/W2120661754', 'https://openalex.org/W2120807317', 'https://openalex.org/W2122249540', 'https://openalex.org/W2124343455', 'https://openalex.org/W2126779285', 'https://openalex.org/W2127856462', 'https://openalex.org/W2129060478', 'https://openalex.org/W2129837805', 'https://openalex.org/W2131602018', 'https://openalex.org/W2133528707', 'https://openalex.org/W2137005514', 'https://openalex.org/W2137159389', 'https://openalex.org/W2137618884', 'https://openalex.org/W2139998450', 'https://openalex.org/W2140747142', 'https://openalex.org/W2140907912', 'https://openalex.org/W2142826108', 'https://openalex.org/W2146604184', 'https://openalex.org/W2152421264', 'https://openalex.org/W2154077173', 'https://openalex.org/W2154274753', 'https://openalex.org/W2156802189', 'https://openalex.org/W2158377392', 'https://openalex.org/W2159845849', 'https://openalex.org/W2160329331', 'https://openalex.org/W2164368066', 'https://openalex.org/W2164802588', 'https://openalex.org/W2167141775', 'https://openalex.org/W2168730865', 'https://openalex.org/W2171190458', 'https://openalex.org/W2171310378', 'https://openalex.org/W2171556874', 'https://openalex.org/W2318605753', 'https://openalex.org/W2330366426', 'https://openalex.org/W2341693810', 'https://openalex.org/W2409927121', 'https://openalex.org/W2414954566', 'https://openalex.org/W2530366440', 'https://openalex.org/W2542944545', 'https://openalex.org/W2582248920', 'https://openalex.org/W275107321', 'https://openalex.org/W2916904419', 'https://openalex.org/W4239462698', 'https://openalex.org/W4250035257'], 'related_works': ['https://openalex.org/W4206757514', 'https://openalex.org/W3157232080', 'https://openalex.org/W2741622630', 'https://openalex.org/W2620774379', 'https://openalex.org/W2528999955', 'https://openalex.org/W2328292166', 'https://openalex.org/W2100224620', 'https://openalex.org/W2054039296', 'https://openalex.org/W2021793782', 'https://openalex.org/W1180701026'], 'abstract_inverted_index': {'Trastuzumab,': [0], 'a': [1, 12, 122], 'therapeutic': [2], 'monoclonal': [3], 'antibody': [4], 'directed': [5], 'against': [6], 'ErbB2,': [7], 'is': [8], 'often': [9], 'noted': [10], 'as': [11], 'successful': [13], 'example': [14], 'of': [15, 74, 105, 111, 124, 137, 168, 174, 177], 'targeted': [16], 'therapy.': [17], 'Trastuzumab': [18], 'improved': [19], 'outcomes': [20], 'for': [21, 133, 156], 'many': [22], 'patients': [23, 165], 'with': [24], 'ErbB2-positive': [25], 'breast': [26], 'and': [27, 38, 91, 97, 170], 'gastric': [28], 'cancers,': [29], 'however,': [30], 'cardiac': [31], 'side': [32], 'effects': [33], '[e.g.,': [34], 'left': [35], 'ventricular': [36], 'dysfunction': [37], 'congestive': [39], 'heart': [40], 'failure': [41], '(CHF)]': [42], 'were': [43], 'reported': [44], 'in': [45], 'the': [46, 62, 71, 109, 134, 144], 'early': [47], 'phase': [48], 'clinical': [49, 57, 72, 92, 161, 175], 'studies.': [50], 'This': [51], 'finding,': [52], 'subsequently': [53], 'corroborated': [54], 'by': [55, 66], 'multiple': [56], 'studies,': [58], 'raised': [59], 'concerns': [60], 'that': [61, 127], 'observed': [63], 'cardiotoxicity': [64, 96, 107], 'induced': [65], 'trastuzumab': [67], 'might': [68], 'adversely': [69], 'impact': [70, 104], 'development': [73, 110], 'other': [75, 112], 'therapeutics': [76], 'targeting': [77, 114], 'ErbB': [78, 115], 'family': [79, 116], 'members.': [80, 117], 'Areas': [81], 'covered:': [82], 'In': [83], 'this': [84], 'review': [85], 'we': [86], 'summarize': [87], 'both': [88], 'basic': [89], 'research': [90], 'findings': [93], 'regarding': [94], 'trastuzumab-induced': [95, 106], 'assess': [98], 'if': [99], 'there': [100], 'has': [101], 'been': [102], 'an': [103], 'on': [108], 'agents': [113], 'Expert': [118], 'opinion:': [119], 'There': [120], 'are': [121, 128], 'number': [123], 'scientific': [125], 'gaps': [126], 'critically': [129], 'important': [130], 'to': [131, 148, 163], 'address': [132], 'continued': [135], 'success': [136], 'HER2-targeted': [138], 'agents.': [139], 'These': [140], 'include:': [141], '1)': [142], 'elucidating': [143], 'molecular': [145], 'mechanisms': [146], 'contributing': [147], 'cardiotoxicity;': [149, 158, 169], '2)': [150], 'developing': [151, 160], 'relevant': [152], 'preclinical': [153], 'testing': [154], 'systems': [155], 'predicting': [157], '3)': [159], 'strategies': [162], 'identify': [164], 'at': [166], 'risk': [167], '4)': [171], 'enhancing': [172], 'management': [173], 'symptoms': [176], 'cardiotoxicity.': [178]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2620774379', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 5}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 5}, {'year': 2018, 'cited_by_count': 4}], 'updated_date': '2024-12-12T23:39:03.799588', 'created_date': '2017-06-09'}